Facet browsing currently unavailable
Page 1 of 882 results
Sort by: relevance publication year
Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates JOURNAL ARTICLE published 6 November 2021 in npj Vaccines |
Antibody enhanced HPLC for serotype-specific quantitation of polysaccharides in pneumococcal conjugate vaccine JOURNAL ARTICLE published 23 January 2023 in npj Vaccines |
Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern JOURNAL ARTICLE published 19 December 2022 in npj Vaccines Research funded by U.S. Department of Health & Human Services | National Institutes of Health (R01AI139092,R01AI157975,R01AI137472,R01AI157975,R01AI139092,R01AI157975,R01AI139092) |
Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2 JOURNAL ARTICLE published 28 June 2022 in npj Vaccines |
Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines JOURNAL ARTICLE published 6 April 2024 in npj Vaccines Research funded by Bill and Melinda Gates Foundation (OPP1111923,OPP1115782) | Aids Fonds (2016019) | European Molecular Biology Organization (STS-7814) |
npj Vaccines JOURNAL published |
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant JOURNAL ARTICLE published 8 March 2022 in npj Vaccines |
Rational development of a combined mRNA vaccine against COVID-19 and influenza JOURNAL ARTICLE published 26 July 2022 in npj Vaccines |
Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques JOURNAL ARTICLE published 23 February 2023 in npj Vaccines Research funded by Bill and Melinda Gates Foundation (INV-027406, INV-006131) |
mRNA vaccine encoding Gn provides protection against severe fever with thrombocytopenia syndrome virus in mice JOURNAL ARTICLE published 31 October 2023 in npj Vaccines Research funded by Korea Health Industry Development Institute (22213MFDS421,22213MFDS421,HV22C0009,HV22C0009) | National Research Foundation of Korea (2021M3E5E3080558,2021M3E5E3080558) |
YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge JOURNAL ARTICLE published 11 July 2023 in npj Vaccines Research funded by KU Leuven (C3/19/057) | EC | Horizon 2020 Framework Programme (733176) |
mRNA-LNP vaccination-based immunotherapy augments CD8+ T cell responses against HPV-positive oropharyngeal cancer JOURNAL ARTICLE published 29 September 2023 in npj Vaccines |
Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections JOURNAL ARTICLE published 3 November 2020 in npj Vaccines |
Insights into vaccines for elderly individuals: from the impacts of immunosenescence to delivery strategies JOURNAL ARTICLE published 10 April 2024 in npj Vaccines |
Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers JOURNAL ARTICLE published 17 August 2021 in npj Vaccines Research funded by Division of Intramural Research, National Institute of Allergy and Infectious Diseases (P01 AI110657) | Bill and Melinda Gates Foundation (OPP1111923,OPP1132237,INV-002022,OPP1111923,OPP1132237,INV-002022) | Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Vici) | EC | Horizon 2020 Framework Programme (681137,681137,681137,681137) | U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (P01 AI110657) |
BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice JOURNAL ARTICLE published 8 March 2024 in npj Vaccines |
Publisher Correction: A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus JOURNAL ARTICLE published 1 February 2018 in npj Vaccines |
Efficacy and safety in mice of repeated, lifelong administration of an ANGPTL3 vaccine JOURNAL ARTICLE published 1 November 2023 in npj Vaccines Research funded by MEXT | Japan Society for the Promotion of Science (21K20935,22K16429) | Japan Agency for Medical Research and Development (JP23ym0126809) |
Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients JOURNAL ARTICLE published 27 September 2023 in npj Vaccines |
Comparing hybrid and regular COVID-19 vaccine-induced immunity against the Omicron epidemic JOURNAL ARTICLE published 15 December 2022 in npj Vaccines Research funded by Food and Health Bureau (COVID-19) |